These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 23500543)

  • 1. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
    Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
    Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A
    De Filippo E; Hinz S; Pellizzari V; Deganutti G; El-Tayeb A; Navarro G; Franco R; Moro S; Schiedel AC; Müller CE
    Biochem Pharmacol; 2020 Feb; 172():113718. PubMed ID: 31751537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.
    Schiedel AC; Hinz S; Thimm D; Sherbiny F; Borrmann T; Maass A; Müller CE
    Biochem Pharmacol; 2011 Aug; 82(4):389-99. PubMed ID: 21620804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
    Hinz S; Lacher SK; Seibt BF; Müller CE
    J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of extracellular cysteine residues in the adenosine A2A receptor.
    De Filippo E; Namasivayam V; Zappe L; El-Tayeb A; Schiedel AC; Müller CE
    Purinergic Signal; 2016 Jun; 12(2):313-29. PubMed ID: 26969588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tritium-labeled agonists as tools for studying adenosine A
    Hinz S; Alnouri WM; Pleiss U; Müller CE
    Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
    Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
    Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor.
    Lebon G; Edwards PC; Leslie AG; Tate CG
    Mol Pharmacol; 2015 Jun; 87(6):907-15. PubMed ID: 25762024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scanning mutagenesis in a yeast system delineates the role of the NPxxY(x)(5,6)F motif and helix 8 of the adenosine A(2B) receptor in G protein coupling.
    Liu R; Nahon D; le Roy B; Lenselink EB; IJzerman AP
    Biochem Pharmacol; 2015 Jun; 95(4):290-300. PubMed ID: 25896847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
    Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domains for activation and inactivation in G protein-coupled receptors--a mutational analysis of constitutive activity of the adenosine A2B receptor.
    Peeters MC; Li Q; Elands R; van Westen GJ; Lenselink EB; Müller CE; IJzerman AP
    Biochem Pharmacol; 2014 Nov; 92(2):348-57. PubMed ID: 25179146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor.
    Peeters MC; van Westen GJ; Guo D; Wisse LE; Müller CE; Beukers MW; Ijzerman AP
    FASEB J; 2011 Feb; 25(2):632-43. PubMed ID: 21030693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.
    Wolska N; Rozalski M
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of adenosine A
    Carlin JL; Jain S; Duroux R; Suresh RR; Xiao C; Auchampach JA; Jacobson KA; Gavrilova O; Reitman ML
    Neuropharmacology; 2018 Sep; 139():268-278. PubMed ID: 29548686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
    Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
    J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
    Vecchio EA; Tan CY; Gregory KJ; Christopoulos A; White PJ; May LT
    J Pharmacol Exp Ther; 2016 Apr; 357(1):36-44. PubMed ID: 26791603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the G protein-coupling selectivity of the native A
    Gao ZG; Inoue A; Jacobson KA
    Biochem Pharmacol; 2018 May; 151():201-213. PubMed ID: 29225130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.
    Rodríguez D; Piñeiro Á; Gutiérrez-de-Terán H
    Biochemistry; 2011 May; 50(19):4194-208. PubMed ID: 21480628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capadenoson, a clinically trialed partial adenosine A
    Baltos JA; Vecchio EA; Harris MA; Qin CX; Ritchie RH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2017 Jul; 135():79-89. PubMed ID: 28344125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.